Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600 · see citing works

Advanced protein glycosylation in diabetes and aging

Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312 · see citing works

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103 · see citing works

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

Vlassara, H., Bucala, R., & Striker, L. J. (1994) · PubMed · Cited by 851 · see citing works

Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress

Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813 · see citing works

Activation of Receptor for Advanced Glycation End Products

Schmidt, A. M., Yan, S. D., Wautier, J., & Stern, D. M. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 792 · see citing works

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

YONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal · doi:10.1042/bj20021371 · Cited by 716 · see citing works

Renal Insufficiency and Heart Failure

McAlister, F. A., Ezekowitz, J. A., Tonelli, M. A., & Armstrong, P. W. (2004) · Circulation · doi:10.1161/01.cir.0000116764.53225.a9 · Cited by 702 · see citing works

RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice

Bucciarelli, L. G., Wendt, T., Qu, W., Lu, Y., Lalla, E., Rong, L., Goova, M. T., Moser, B., Kislinger, T., Lee, D. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039325.03698.36 · Cited by 562 · see citing works

Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo

Dyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535 · see citing works

Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors

Grandhee, S. K., & Monnier, V. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99006-x · Cited by 459 · see citing works

Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy

Yamagishi, S., & Imaizumi, T. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054367300 · Cited by 455 · see citing works

The Receptor for Advanced Glycation End Products Is Induced by the Glycation Products Themselves and Tumor Necrosis Factor-α through Nuclear Factor-κB, and by 17β-Estradiol through Sp-1 in Human Vascular Endothelial Cells

Tanaka, N., Yonekura, H., Yamagishi, S., Fujimori, H., Yamamoto, Y., & Yamamoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001235200 · Cited by 425 · see citing works

Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men

Falcone, C., Emanuele, E., D’Angelo, A., Buzzi, M. P., Belvito, C., Cuccia, M., & Geroldi, D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000160342.20342.00 · Cited by 378 · see citing works

Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis

Koyama, H., Shoji, T., Yokoyama, H., Motoyama, K., Mori, K., Fukumoto, S., Emoto, M., Shoji, T., Tamei, H., Matsuki, H., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000190660.32863.cd · Cited by 311 · see citing works

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

Kilhovd, B. K., Berg, T. J., Birkeland, K. I., Thorsby, P. M., & Hanssen, K. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1543 · Cited by 269 · see citing works

Purification and Characterization of Mouse Soluble Receptor for Advanced Glycation End Products (sRAGE)

Hanford, L. E., Enghild, J. J., Valnickova, Z., Petersen, S. V., Schaefer, L. M., Schaefer, T. M., Reinhart, T. A., & Oury, T. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409782200 · Cited by 217 · see citing works

Immunological Evidence that Non-carboxymethyllysine Advanced Glycation End-products Are Produced from Short Chain Sugars and Dicarbonyl Compounds in vivo

Takeuchi, M., Makita, Z., Bucala, R., Suzuki, T., Koike, T., & Kameda, Y. (2000) · Molecular Medicine · doi:10.1007/bf03401779 · Cited by 192 · see citing works

Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension

Geroldi, D., Falcone, C., Emanuele, E., D’Angelo, A., Calcagnino, M. M., Buzzi, M. P., Scioli, G. A., & Fogari, R. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000177535.45785.64 · Cited by 190 · see citing works

Atherosclerosis and diabetes: The rage connection

Schmidt, A. M., & Stern, D. M. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0082-4 · Cited by 166 · see citing works

Tissue-specific expression patterns of the RAGE receptor and its soluble forms—a result of regulated alternative splicing?

Schlueter, C., Hauke, S., Flohr, A. M., Rogalla, P., & Bullerdiek, J. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2003.08.008 · Cited by 157 · see citing works

Regulation of Human Melanoma Growth and Metastasis by AGE–AGE Receptor Interactions

Abe, R., Shimizu, T., Sugawara, H., Watanabe, H., Nakamura, H., Choei, H., Sasaki, N., Yamagishi, S., Shimizu, H., & Takeuchi, M. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22218.x · Cited by 145 · see citing works

Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells

Park, I. H. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.11.027 · Cited by 140 · see citing works

Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.

Ferri, C., Desideri, G., Baldoncini, R., Bellini, C., Angelis, C. D., Mazzocchi, C., & Santucci, A. (1998) · Diabetes · doi:10.2337/diabetes.47.4.660 · Cited by 127 · see citing works

Involvement of Advanced Glycation End-products (AGEs) in Alzheimers Disease

Takeuchi, M., Kikuchi, S., Sasaki, N., Suzuki, T., 渡井孝幸, Iwaki, M., Bucala, R., & Yamagishi, S. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480582 · Cited by 127 · see citing works

Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease

Hudson, B. I., Harja, E., Moser, B., & Schmidt, A. M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000164804.05324.8b · Cited by 112 · see citing works

Advanced Glycation End Products in Nondiabetic Patients With Coronary Artery Disease

Kanauchi, M., Tsujimoto, N., & Hashimoto, T. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1620 · Cited by 112 · see citing works

Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension

Nakamura, K., Yamagishi, S., Nakamura, Y., Takenaka, K., Matsui, T., Jinnouchi, Y., & Imaizumi, T. (2005) · Microvascular Research · doi:10.1016/j.mvr.2005.10.002 · Cited by 101 · see citing works

Upregulation of RAGE and its ligands in proliferative retinal disease

Pachydaki, S. I., Tari, S. R., Lee, S. E., Ma, W., Tseng, J., Sosunov, A. A., Cataldergirmen, G., Scarmeas, N., Caspersen, C. S., Chang, S., et al. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.09.022 · Cited by 101 · see citing works

Dual Glucagon Recognition by Pancreatic β-Cells via Glucagon and Glucagon-Like Peptide 1 Receptors

Moens, K., Flamez, D., Schravendijk, C. V., Ling, Z., PIPELEERS, D. G., & Schuit, F. C. (1998) · Diabetes · doi:10.2337/diab.47.1.66 · Cited by 97 · see citing works

Beraprost Sodium, a Prostaglandin I2 Analogue, Protects Against Advanced Glycation End Products-induced Injury in Cultured Retinal Pericytes

Yamagishi, S., Amano, S., Inagaki, Y., Okamoto, T., Takeuchi, M., & Makita, Z. (2002) · Molecular Medicine · doi:10.1007/bf03402164 · Cited by 45 · see citing works

An evaluation of level of oxidative stress and protein glycation in nondiabetic undialyzed chronic renal failure patients

Selvaraj, N., Bobby, Z., Das, A. K., Ramesh, R., & Koner, B. C. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00211-5 · Cited by 43 · see citing works

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation

Sparvero, L. J., Asafu-Adjei, D. A., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A. A., Zeh, H. J., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-17 · Cited by 625 · see citing works

Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases

Moldogazieva, N. T., Mokhosoev, I. M., Melnikova, T. I., Porozov, Y. B., & Terentiev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3085756 · Cited by 504 · see citing works

Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective

Bongarzone, S., Savickas, V., Luzi, F., & Gee, A. D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00058 · Cited by 313 · see citing works

Soy isoflavones attenuate oxidative stress and improve parameters related to aging and Alzheimer’s disease in C57BL/6J mice treated with d-galactose

Hsieh, H.-M., Wu, W., & Hu, M. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.12.026 · Cited by 199 · see citing works

AGEs, RAGEs and s-RAGE; friend or foe for cancer

Ahmad, S., Khan, H., Siddiqui, Z., Khan, M. Y., Rehman, S., Shahab, U., Godovikova, T. S., Silnikov, V. N., & Moinuddin, M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.001 · Cited by 196 · see citing works

The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction

Sergi, D., Boulestin, H., Campbell, F. M., & Williams, L. M. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900934 · Cited by 194 · see citing works

The Extracellular Region of the Receptor for Advanced Glycation End Products Is Composed of Two Independent Structural Units

Dattilo, B. M., Fritz, G., Leclerc, E., Kooi, C. W. V., Heizmann, C. W., & Chazin, W. (2007) · Biochemistry · doi:10.1021/bi7003735 · Cited by 193 · see citing works

Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases

Maillard-Lefebvre, H., Boulanger, E., Daroux, M., Gaxatte, C., Hudson, B. I., & Lambert, M. (2009) · Rheumatology · doi:10.1093/rheumatology/kep199 · Cited by 190 · see citing works

Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes

Yamagishi, S., Nakamura, N., Suematsu, M., Kaseda, K., & Matsui, T. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00067 · Cited by 176 · see citing works

Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor

Ishibashi, Y., Matsui, T., Maeda, S., Higashimoto, Y., & Yamagishi, S. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-125 · Cited by 164 · see citing works

RAGE and Soluble RAGE: Potential Therapeutic Targets for Cardiovascular Diseases

Koyama, H., Yamamoto, H., & Nishizawà, Y. (2007) · Molecular Medicine · doi:10.2119/2007-00087.koyama · Cited by 156 · see citing works

Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications

Yamagishi, S., Nakamura, K., Matsui, T., Ueda, S., Fukami, K., & Okuda, S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.983 · Cited by 138 · see citing works

Serum Levels of sRAGE, the Soluble Form of Receptor for Advanced Glycation End Products, Are Associated with Inflammatory Markers in Patients with Type 2 Diabetes

Nakamura, K., Yamagishi, S., Adachi, H., Kurita‐Nakamura, Y., Matsui, T., Yoshida, T., & Imaizumi, T. (2007) · Molecular Medicine · doi:10.2119/2006-00090.nakamura · Cited by 134 · see citing works

sRAGE is Elevated in Septic Patients and Associated With Patients Outcome

Bopp, C., Hofer, S., Weitz, J., Bierhaus, A., Nawroth, P. P., Martin, E., Büchler, M. W., & Weigand, M. A. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.07.014 · Cited by 131 · see citing works

Soluble form of a receptor for advanced glycation end products sRAGE as a biomarker

Yamagishi, S. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e178 · Cited by 130 · see citing works

Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis

Kwak, T., Drews‐Elger, K., Ergonul, A. B., Miller, P. C., Braley, A. E., Hwang, G. H., Zhao, D., Besser, A., Yamamoto, Y., Yamamoto, H., et al. (2016) · Oncogene · doi:10.1038/onc.2016.324 · Cited by 130 · see citing works

Involvement of Toxic AGEs (TAGE) in the Pathogenesis of Diabetic Vascular Complications and Alzheimer's Disease

Takeuchi, M., & Yamagishi, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0974 · Cited by 122 · see citing works

Low Levels of Serum Soluble Receptors for Advanced Glycation End Products, Biomarkers for Disease State: Myth or Reality

Prasad, K. (2014) · International Journal of Angiology · doi:10.1055/s-0033-1363423 · Cited by 118 · see citing works

Diabetes Mellitus Activates Signal Transduction Pathways Resulting in Vascular Endothelial Growth Factor Resistance of Human Monocytes

Tchaikovski, V., Olieslagers, S., Böhmer, F. D., & Waltenberger, J. L. (2009) · Circulation · doi:10.1161/circulationaha.108.817528 · Cited by 115 · see citing works

Clinical Significance of Serum HMGB-1 and sRAGE Levels in Systemic Sclerosis: Association with Disease Severity

Yoshizaki, A., Komura, K., Iwata, Y., Ogawa, F., Hara, T., Muroi, E., Takenaka, M., Shimizu, K., Hasegawa, M., Fujimoto, M., et al. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9252-x · Cited by 111 · see citing works

Association of Polymorphism in the Receptor for Advanced Glycation End Products (RAGE) Gene with Circulating RAGE Levels

Gaens, K. H. J., Ferreira, I., Kallen, C., van Greevenbroek, M. M. J., Blaak, E. E., Feskens, E. J. M., Dekker, J. M., Nijpels, G., Heine, R. J., Hart, L. M. ‘., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1067 · Cited by 100 · see citing works

RAGE: a new frontier in chronic airways disease

Sukkar, M. B., Ullah, M. A., Gan, W. J., Wark, P. A. B., Chung, K. F., Hughes, J. M., Armour, C. L., & Phipps, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01984.x · Cited by 98 · see citing works

Role of advanced glycation end products and insulin resistance in diabetic nephropathy

Parwani, K., & Mandal, P. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1797106 · Cited by 97 · see citing works

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes

Nakamura, K., Yamagishi, S., Adachi, H., Matsui, T., Kurita‐Nakamura, Y., Takeuchi, M., Inoue, H., & Imaizumi, T. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.09.004 · Cited by 96 · see citing works

Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy

Takeuchi, M., Takino, J.-I., & Yamagishi, S. (2010) · Current Drug Targets · doi:10.2174/1389450111009011468 · Cited by 95 · see citing works

Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases: Links in a Chain?

Davis, K. E., Prasad, C., Vijayagopal, P., Juma, S., & Imrhan, V. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.744738 · Cited by 94 · see citing works

Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes

Tam, X., Shiu, S. W. M., Leng, L., Bucala, R., Betteridge, D. J., & Tan, K. C. B. (2010) · Clinical Science · doi:10.1042/cs20100256 · Cited by 89 · see citing works

RAGE and cardiovascular disease

Shim, C. Y. (2010) · Frontiers in bioscience · doi:10.2741/3700 · Cited by 86 · see citing works

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein‐1 (MCP‐1) levels in patients with type 2 diabetes

Nakamura, K., Yamagishi, S., Adachi, H., Matsui, T., Kurita‐Nakamura, Y., Takeuchi, M., Inoue, H., & Imaizumi, T. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.766 · Cited by 86 · see citing works

Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients

Kalousová, M., Jáchymová, M., Mestek, O., Hodkova, M., Kazderová, M., Tesař, V., & Zima, T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm050 · Cited by 79 · see citing works

Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes

Lu, L., Pu, L. J., Zhang, Q., Wang, L. J., Kang, S., Zhang, R., Chen, Q., Wang, J. G., Caterina, R. D., & Shen, W. F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.045 · Cited by 77 · see citing works

The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?

Creagh-Brown, B. C., Quinlan, G. J., Evans, T. W., & Burke-Gaffney, A. C. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1952-z · Cited by 76 · see citing works

Diabetes Mellitus and Atrial Remodeling: Mechanisms and Potential Upstream Therapies

Zhang, Q., Liu, T., Ng, C. Y., & Li, G. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12089 · Cited by 74 · see citing works

Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress.

Younessi, P., & Yoonessi, A. (2011) · Europe PMC (PubMed Central) · Cited by 72 · see citing works

Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal Cancer

Jiao, L., Taylor, P. R., Weinstein, S. J., Graubard, B. I., Virtamo, J. R. K., Albanes, D., & Stolzenberg‐Solomon, R. Z. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0066 · Cited by 71 · see citing works

The structures of two polysaccharides from Angelica sinensis and their effects on hepatic insulin resistance through blocking RAGE

Liu, W., Li, Z., Feng, C., Hu, S., Yang, X., Xiao, K., Nong, Q.-N., Xiao, Q., Wu, K., Li, X., et al. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.119001 · Cited by 69 · see citing works

Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study

Nin, J. W. M., Ferreira, I., Schalkwijk, C., Prins, M. H., Chaturvedi, N., Fuller, J., Stehouwer, C. D. A., & EURODIAB Prospective Complications Study Group (2009) · Diabetologia · doi:10.1007/s00125-009-1263-5 · Cited by 69 · see citing works

Evidence That Serum Levels of the Soluble Receptor for Advanced Glycation End Products Are Inversely Associated with Pancreatic Cancer Risk: A Prospective Study

Jiao, L., Weinstein, S. J., Albanes, D., Taylor, P. R., Graubard, B. I., Virtamo, J. R. K., & Stolzenberg‐Solomon, R. Z. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2573 · Cited by 70 · see citing works

Plasma Concentrations of High-Mobility Group Box Protein 1, Soluble Receptor for Advanced Glycation End-Products and Circulating DNA in Patients with Acute Pancreatitis

Kocsis, Á. K., Szabolcs, A., Hofner, P., Takács, T., Farkas, G., Boda, K., & Mándi, Y. (2009) · Pancreatology · doi:10.1159/000181172 · Cited by 68 · see citing works

Soluble Receptor for Advanced Glycation End Products (RAGE) is a Prognostic Factor for Heart Failure

Koyama, Y., Takeishi, Y., Niizeki, T., Suzuki, S., Kitahara, T., Sasaki, T., & Kubota, I. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.10.019 · Cited by 67 · see citing works

Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products

Mulder, D. J., van Haelst, P. L., Groß, S., de Leeuw, K., Bijzet, J., Graaff, R., Gans, R. O. B., Zijlstra, F., & Smit, A. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.027 · Cited by 63 · see citing works

Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention

Yamagishi, S. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0618 · Cited by 62 · see citing works

Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis

Narvaez-Rivera, R. M., Rendón, A., Salinas-Carmona, M. C., & Rosas-Taraco, A. G. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-15 · Cited by 61 · see citing works

Evidence for a role of advanced glycation end products in atrial fibrillation

Raposeiras‐Roubín, S., Rodiño‐Janeiro, B. K., Grigorian-Shamagian, L., Seoane‐Blanco, A., Moure‐González, M., Roman, A. V., Álvarez, E., & González‐Juanatey, J. R. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.05.072 · Cited by 59 · see citing works

Cystic fibrosis-related diabetes and lung disease: an update

Prentice, B. J., Jaffé, A., Hameed, S., Verge, C. F., Waters, S. A., & Widger, J. (2021) · European Respiratory Review · doi:10.1183/16000617.0293-2020 · Cited by 59 · see citing works

Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS)

Hudson, B. I., Moon, Y. P., Kalea, A. Z., Khatri, M., Marquez, C., Schmidt, A. M., Paik, M. C., Yoshita, M., Sacco, R. L., DeCarli, C. S., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.024 · Cited by 59 · see citing works

Alternative Splicing of the RAGE Cytoplasmic Domain Regulates Cell Signaling and Function

Jules, J., Maiguel, D. A., & Hudson, B. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078267 · Cited by 57 · see citing works

The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity

Brix, J., Höllerl, F., Kopp, H., Schernthaner, G.-H., & Schernthaner, G.-H. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.107 · Cited by 56 · see citing works

V domain of RAGE interacts with AGEs on prostate carcinoma cells

Allmen, E. U., Koch, M., Fritz, G., & Legler, D. F. (2008) · The Prostate · doi:10.1002/pros.20736 · Cited by 55 · see citing works

Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases

Takeuchi, M. (2016) · Diagnostics · doi:10.3390/diagnostics6020023 · Cited by 52 · see citing works

Low levels of soluble receptor for advanced glycation end products in non-ST elevation myocardial infarction patients

McNair, E., Wells, C., Qureshi, A., Basran, R., Pearce, C., Orvold, J., Devilliers, J., & Prasad, K. (2009) · International Journal of Angiology · doi:10.1055/s-0031-1278352 · Cited by 51 · see citing works

Serum Levels of Advanced Glycation End Products (AGEs) are Inversely Associated with the Number and Migratory Activity of Circulating Endothelial Progenitor Cells in Apparently Healthy Subjects

Ueda, S., Yamagishi, S., Matsui, T., Noda, Y., Ueda, S., Jinnouchi, Y., Sasaki, K., Takeuchi, M., & Imaizumi, T. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00264.x · Cited by 50 · see citing works

Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy

Kerkeni, M., Saïdi, A., Bouzidi, H., Yahya, S. B., & Hammami, M. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.07.006 · Cited by 50 · see citing works

Advanced glycation end products in senile diabetic and nondiabetic patients with cataract

Gul, A., Rahman, M. A., Salim, A., & Sımjee, S. U. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.04.001 · Cited by 49 · see citing works

Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women

Dozio, E., Briganti, S., Delnevo, A., Vianello, E., Ermetici, F., Secchi, F., Sardanelli, F., Morricone, L. F., Malavazos, A. E., & Romanelli, M. M. C. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1291-0 · Cited by 48 · see citing works

Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle

Takeuchi, M. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00614-3 · Cited by 50 · see citing works

The Role of Receptor for Advanced Glycation End Products in Airway Inflammation in CF and CF related Diabetes

Mulrennan, S. A., Baltic, S., Aggarwal, S. R., Wood, J., Miranda, A., Frost, F. A., Kaye, J. M., & Thompson, P. J. (2015) · Scientific Reports · doi:10.1038/srep08931 · Cited by 47 · see citing works

Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock

Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Suzuki, T., Ueda, Y., Yamada, S., Shoji, H., Takeuchi, M., Ueda, S., et al. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.05.002 · Cited by 46 · see citing works

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

Iłżecka, J. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01133.x · Cited by 47 · see citing works

Therapeutic potential of vitamin D in AGE/RAGE-related cardiovascular diseases

Lee, T., Kao, Y., Chen, Y., Chao, T., & Lee, T.-I. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03204-3 · Cited by 46 · see citing works

Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms

Sterenczak, K. A., Willenbrock, S., Barann, M., Klemke, M., Soller, J. T., Eberle, N., Nolte, I. J. A., Bullerdiek, J., & Escobar, H. M. (2008) · Gene · doi:10.1016/j.gene.2008.10.027 · Cited by 47 · see citing works

Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report

Nakamura, I., Oyama, J., Komoda, H., Shiraki, A., Sakamoto, Y., Taguchi, I., Atsushi, H., Komatsu, A., Takeuchi, M., Yamagishi, S., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-15 · Cited by 44 · see citing works

AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease

Prasad, K., Dhar, I., Zhou, Q., Elmoselhi, H., Shoker, M., & SHOKER, A. S. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2829-4 · Cited by 44 · see citing works

Soluble form of receptor for advanced glycation end products and incidence of new cardiovascular events among patients with cardiovascular disease

Reichert, S., Triebert, U., Santos, A. N., Hofmann, B., Schaller, H., Schlitt, A., & Schulz, S. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.08.015 · Cited by 44 · see citing works

Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictor of Restenosis Following Percutaneous Coronary Intervention

McNair, E. D., Wells, C. R., Qureshi, A. M., Basran, R., Pearce, C., Orvold, J., Devilliers, J., & Prasad, K. (2010) · Clinical Cardiology · doi:10.1002/clc.20815 · Cited by 44 · see citing works

Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function

Braley, A. E., Kwak, T., Jules, J., Harja, E., Landgraf, R., & Hudson, B. I. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.702399 · Cited by 43 · see citing works

Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat

Davis, K. E., Prasad, C., Vijayagopal, P., Juma, S., ADAMS-HUET, B. A., & Imrhan, V. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003487 · Cited by 41 · see citing works

Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects

Šebeková, K., Krivošíková, Z., & Gajdoš, M. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0879 · Cited by 41 · see citing works

The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome

Steenbeke, M., Bruyne, S. D., Buyzere, M. D., Lapauw, B., Speeckaert, R., Petrović, M., Delanghe, J., & Speeckaert, M. M. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1791045 · Cited by 41 · see citing works

Effects of Toxic AGEs (TAGE) on Human Health

Takeuchi, M., Sakai, A., Takata, T., Takino, J.-I., & Koriyama, Y. (2022) · Cells · doi:10.3390/cells11142178 · Cited by 40 · see citing works

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

Koerich, S., Parreira, G. M., de Almeida, D. L., Vieira, R. P., & de Oliveira, A. C. P. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220922153903 · Cited by 40 · see citing works

Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults

Davis, K. E., Prasad, C., Vijayagopal, P., Juma, S., & Imrhan, V. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.04.012 · Cited by 38 · see citing works

Advanced glycation end products and diabetes and other metabolic indicators

Jiang, T., Zhang, Y., Dai, F., Liu, C., Hu, H., & Zhang, Q. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00873-2 · Cited by 38 · see citing works

Serum Levels of Soluble Form of Receptor for Advanced Glycation End Products (sRAGE) May Reflect Tissue RAGE Expression In Diabetes

Yamagishi, S., & Imaizumi, T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.139923 · Cited by 35 · see citing works

ORIGINAL ARTICLE: Glycation Endproducts, Soluble Receptor for Advanced Glycation Endproducts and Cytokines in Diabetic and Non‐diabetic Pregnancies

Pertyńska−Marczewska, M., Głowacka, E., Sobczak, M., Cypryk, K., & Wilczyński, J. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00679.x · Cited by 34 · see citing works

Decreased plasma sRAGE levels in COPD: influence of oxygen therapy

Gopal, P., Rutten, E. P. A., Dentener, M. A., Wouters, E. F. �., & Reynaert, N. L. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02646.x · Cited by 33 · see citing works

Relation of Soluble Receptor for Advanced Glycation End Products to Predict Mortality in Patients With Chronic Heart Failure Independently of Seattle Heart Failure Score

Raposeiras‐Roubín, S., Rodiño‐Janeiro, B. K., Grigorian-Shamagian, L., Moure‐González, M., Seoane‐Blanco, A., Roman, A. V., Bonet, L. A., Álvarez, E., & González‐Juanatey, J. R. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.11.011 · Cited by 34 · see citing works

Soluble receptor for advanced glycation end products as a potential biomarker to predict weight loss and improvement of insulin sensitivity by a very low calorie diet of obese human subjects

Hagen, I., Schulte, D. M., Müller, N., Martinsen, J., Türk, K., Hedderich, J., Schreiber, S., & Laudes, M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.022 · Cited by 33 · see citing works

Advanced Glycosylation End Products and Nutrition—A Possible Relation with Diabetic Atherosclerosis and How to Prevent It

Xanthis, A., Hatzitolios, A. I., Koliakos, G., & Tatola, V. (2007) · Journal of Food Science · doi:10.1111/j.1750-3841.2007.00508.x · Cited by 33 · see citing works

Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies

Takeuchi, M. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i12.880 · Cited by 32 · see citing works

Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma

Takino, J.-I. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i23.2459 · Cited by 32 · see citing works

Calcium Channel Blocker Inhibition of AGE and RAGE Axis Limits Renal Injury in Nondiabetic Patients With Stage I or II Chronic Kidney Disease

Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Koide, H., Ueda, Y., Takeuchi, M., & Yamagishi, S. (2011) · Clinical Cardiology · doi:10.1002/clc.20885 · Cited by 31 · see citing works

Effects of Nitric Oxide and Antioxidants on Advanced Glycation End Products-Induced Hypertrophic Growth in Human Renal Tubular Cells

Huang, J., Chuang, L., Guh, J., & Huang, Y.-J. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp134 · Cited by 31 · see citing works

Endogenous Secretory Receptor for Advanced Glycation End-Products and Cardiovascular Disease in End-Stage Renal Disease

Nishizawà, Y., & Koyama, H. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2007.10.016 · Cited by 27 · see citing works

Can advanced glycation end‐products and their receptors be affected by weight loss? A systematic review

Tavares, J. F., Ribeiro, P. V. D. M., Coelho, O. G. L., da Silva, L. E., & Alfenas, R. D. C. G. (2020) · Obesity Reviews · doi:10.1111/obr.13000 · Cited by 27 · see citing works

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis

Saku, K., Tahara, N., Takaseya, T., Otsuka, H., Takagi, K., Shojima, T., Shintani, Y., Zaima, Y., Kikusaki, S., Fukuda, T., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015261 · Cited by 26 · see citing works

Could Oxidative Stress Associate with Age Products in Cataractogenesis?

Gul, A., Rahman, M. A., Hasnain, S. N., Salim, A., & Sımjee, S. U. (2008) · Current Eye Research · doi:10.1080/02713680802250939 · Cited by 26 · see citing works

Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism

Caspar‐Bell, G., Dhar, I., & Prasad, K. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2669-2 · Cited by 26 · see citing works

Biomarkers Associated with Atrial Fibrosis and Remodeling

Dilaveris, P., Antoniou, C. K., Manolakou, P., Tsiamis, E. G., Gatzoulis, K. A., & Tousoulis, D. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170918122502 · Cited by 26 · see citing works

RAGE expression and NF‐κB activation attenuated by extracellular domain of RAGE in human salivary gland cell line

Chuong, C. F., Katz, J., Pauley, K. M., Bulosan, M., & Cha, S. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21873 · Cited by 25 · see citing works

Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension

Gryszczyńska, B., Budzyń, M., Krasińska, B., Osińska, A., Boruczkowski, M., Kaczmarek, M., Bukowska, A., Iskra, M., & Kasprzak, M. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163942 · Cited by 25 · see citing works

Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy

Takeuchi, M., Takino, J.-I., & Yamagishi, S. (2010) · Journal of Ophthalmology · doi:10.1155/2010/170393 · Cited by 25 · see citing works

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases

Koyama, H., Yamamoto, H., & Nishizawà, Y. (2007) · Biomarker Insights · doi:10.1177/117727190700200021 · Cited by 24 · see citing works

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases.

Koyama, H., Yamamoto, H., & Nishizawà, Y. (2007) · PubMed Central · Cited by 24 · see citing works

sRAGE in septic shock: a potential biomarker of mortality

Hamasaki, M. Y., Barbeiro, H. V., de Souza, H. P., Machado, M. C. C., & da Silva, F. P. (2014) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20140060 · Cited by 23 · see citing works

Lower Serum Endogenous Secretory Receptor for Advanced Glycation End Product Level as a Risk Factor of Metabolic Syndrome Among Japanese Adult Men: A 2-Year Longitudinal Study

Momma, H., Niu, K., Kobayashi, Y., Huang, C. X., Chujo, M., Otomo, A., Tadaura, H., Miyata, T., & Nagatomi, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2936 · Cited by 21 · see citing works

Involvement of Intracellular TAGE and the TAGE–RAGE–ROS Axis in the Onset and Progression of NAFLD/NASH

Sakai, A., Takeda, K., & Takeuchi, M. (2023) · Antioxidants · doi:10.3390/antiox12030748 · Cited by 20 · see citing works

Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients

Nakamura, K., Adachi, H., Matsui, T., Kurita, Y., Takeuchi, M., & Yamagishi, S. (2009) · Metabolism · doi:10.1016/j.metabol.2008.10.020 · Cited by 19 · see citing works

High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis

Basta, G., Castagnini, M., Turco, S. D., Epistolato, M. C., Righini, P., Sangiorgi, G., Caterina, R. D., & Tanganelli, P. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02212.x · Cited by 19 · see citing works

Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study

Gurecká, R., Koborová, I., Csongová, M., Šebek, J., & Šebeková, K. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9696-9 · Cited by 18 · see citing works

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects

Nakamura, K., Yamagishi, S., Matsui, T., Adachi, H., Takeuchi, M., & Imaizumi, T. (2007) · Clinical and Experimental Medicine · doi:10.1007/s10238-007-0146-7 · Cited by 57 · see citing works

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

Tan, K. C. B., Shiu, S. W. M., Chow, W. S., Leng, L., Bucala, R., & Betteridge, D. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0394-1 · Cited by 159 · see citing works

Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population

Norata, G. D., Garlaschelli, K., Grigore, L., Tibolla, G., Raselli, S., Redaelli, L., Buccianti, G., & Catapano, A. L. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.03.004 · Cited by 105 · see citing works

Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease

Nakamura, K., Yamagishi, S., Adachi, H., Kurita‐Nakamura, Y., Matsui, T., Yoshida, T., Sato, A., & Imaizumi, T. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.690 · Cited by 143 · see citing works

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes

Nakamura, K., Yamagishi, S., Adachi, H., Matsui, T., Kurita‐Nakamura, Y., Takeuchi, M., Inoue, H., & Imaizumi, T. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.09.004 · Cited by 96 · see citing works